THÔNG TIN TÀI LIỆU
Thông tin cơ bản
Định dạng | |
---|---|
Số trang | 47 |
Dung lượng | 615,78 KB |
Nội dung
Ngày đăng: 10/08/2014, 18:21
Nguồn tham khảo
Tài liệu tham khảo | Loại | Chi tiết |
---|---|---|
1. Kushida CA, Littner MR, Hirshkowitz M, et al. Practice parameters for the use of con- tinuous and bilevel positive airway pressure devices to treat adult patients with sleep- related breathing disorders. Sleep 2006; 29(3):375–380 | Khác | |
2. Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by con- tinuous positive airway pressure applied through the nares. Lancet 1981;317(8225):862–865 | Khác | |
3. Wagner DR, Pollak CP, Weitzman ED. Nocturnal nasal-airway pressure for sleep apnea. N Engl J Med 1983; 308(8):461–462 | Khác | |
4. Krieger J, Weitzenblum E, Monassier JP, Stoeckel C, Kurtz D. Dangerous hypoxaemia during continuous positive airway pressure treatment of obstructive sleep apnoea.Lancet 1983; 2(8364):1429–1430 | Khác | |
5. Bradley D, Phillipson EA. The treatment of obstructive sleep apnea. Separating the wheat from the chaff. Am Rev Respir Dis 1983; 128(4):583–586 | Khác | |
6. Grunstein RR, Dodd MJ, Costas L, Sullivan CE. Home nasal CPAP for sleep apnea- acceptance of home therapy and its usefulness. Aust N Z J Med 1986; 16:635 | Khác | |
7. Grunstein RR. Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea. Thorax 1995; 50(10):1106–1113 | Khác | |
8. Grunstein RR, Hedner J, Grote L. Treatment options for sleep apnoea. Drugs 2001; 61(2):237–251 | Khác | |
9. Buchanan PR, Grunstein RR. Chapter: Neuropharmacology of obstructive sleep apnea and central apnea. Clinical Pharmacology of Sleep. Switzerland: Birkhauser, 2006 | Khác | |
10. Abad VC, Guilleminault C. Pharmacological management of sleep apnoea. Expert Opin Pharmacother 2006; 7(1):11–23 | Khác | |
11. Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure.N Engl J Med 1971; 284(24):1333–1340 | Khác | |
12. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978; 44(6):931–938 | Khác | |
13. Strohl KP, Redline S. Nasal CPAP therapy, upper airway muscle activation, and obstructive sleep apnea. Am Rev Respir Dis 1986; 134(3):555–558 | Khác | |
14. Schwab RJ, Pack AI, Gupta KB, et al. Upper airway and soft tissue structural changes induced by CPAP in normal subjects. Am J Respir Crit Care Med 1996; 154(4 Pt 1):1106–1116 | Khác | |
15. Issa FG, Sullivan CE. Reversal of central sleep apnea using nasal CPAP. Chest 1986; 90(2):165–171 | Khác | |
16. Thomas RJ, Daly RW, Weiss JW. Low-concentration carbon dioxide is an effective adjunct to positive airway pressure in the treatment of refractory mixed central and obstructive sleep-disordered breathing. Sleep 2005; 28(1):69–77 | Khác | |
17. Zozula R, Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 2001; 7(6):391–398 | Khác | |
18. Fitzpatrick MF, Alloway CE, Wakeford TM, MacLean AW, Munt PW, Day AG. Can patients with obstructive sleep apnea titrate their own continuous positive airway pressure? Am J Respir Crit Care Med 2003; 167(5):716–722 | Khác | |
19. Hukins C. Comparative study of autotitrating and fixed-pressure CPAP in the home: a randomized, single-blind crossover trial. Sleep 2004; 27(8):1512–1517 | Khác | |
20. Hukins CA. Arbitrary-pressure continuous positive airway pressure for obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2005; 171(5):500–505 | Khác |
TỪ KHÓA LIÊN QUAN
TÀI LIỆU CÙNG NGƯỜI DÙNG
TÀI LIỆU LIÊN QUAN